KIR3DL1 and non-small cell lung carcinoma: Li Y et al. reported no differences in the KIR genotype and haplotype frequencies between the NSCLC patients and control groups [193], while Ty et al. observed that the expression of KIR2DS4del was associated with a significantly decreased survival time in metastatic NSCLC in a Chinese population [194].